These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 16244516)
1. Interferon-alpha-induced depression: when a randomized trial is not a randomized controlled trial. Ranjith G Psychother Psychosom; 2005; 74(6):387; author reply 387-8. PubMed ID: 16244516 [No Abstract] [Full Text] [Related]
2. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C]. García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422 [No Abstract] [Full Text] [Related]
8. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression. Hauser P Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102 [TBL] [Abstract][Full Text] [Related]
9. [ANRS HC 02 RIBAVIC: summary and recommandations]. Bani-Sadr F Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S104-5. PubMed ID: 19375036 [No Abstract] [Full Text] [Related]
18. Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C. Onishi S; Nagashima T; Kimura H; Matsuyama Y; Yoshio T; Minota S Lupus; 2010 May; 19(6):753-5. PubMed ID: 20064909 [TBL] [Abstract][Full Text] [Related]